share_log

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-8：員工福利計劃證券登記
美股sec公告 ·  04/27 04:43
牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.
Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.
總部位於特拉華州的Cardio Diagnostics Holdings, Inc. 於2024年4月26日向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明。該文件的目的是爲Cardio Diagnostics Holdings, Inc.2022年股權激勵計劃再註冊1,060,458股普通股。此舉是在2023年3月22日根據同一計劃註冊3,265,516股股票之後採取的。新註冊的股票與先前註冊的股票屬於同一類別。公司截至2023年12月31日的財政年度的年度報告以引用方式納入本註冊聲明。Cardio Diagnostics Holdings還承諾在發行期內提交生效後的修正案，以反映任何重大變化。
總部位於特拉華州的Cardio Diagnostics Holdings, Inc. 於2024年4月26日向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明。該文件的目的是爲Cardio Diagnostics Holdings, Inc.2022年股權激勵計劃再註冊1,060,458股普通股。此舉是在2023年3月22日根據同一計劃註冊3,265,516股股票之後採取的。新註冊的股票與先前註冊的股票屬於同一類別。公司截至2023年12月31日的財政年度的年度報告以引用方式納入本註冊聲明。Cardio Diagnostics Holdings還承諾在發行期內提交生效後的修正案，以反映任何重大變化。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。